Roche (VTX:ROG) Given a CHF 300 Price Target by Goldman Sachs Analysts

Roche (VTX:ROG) has been assigned a CHF 300 price objective by equities researchers at Goldman Sachs in a research report issued on Tuesday, March 27th. The brokerage presently has a “buy” rating on the healthcare company’s stock. Goldman Sachs’ target price suggests a potential upside of 36.61% from the stock’s current price.

ROG has been the topic of a number of other research reports. Societe Generale set a CHF 190 price target on Roche and gave the stock a “sell” rating in a report on Monday, January 15th. Jefferies Group set a CHF 300 target price on Roche and gave the company a “buy” rating in a research note on Friday, January 5th. JPMorgan Chase set a CHF 300 target price on Roche and gave the company a “buy” rating in a research note on Thursday, January 4th. Barclays set a CHF 305 price target on Roche and gave the stock a “buy” rating in a research note on Thursday, December 21st. Finally, Deutsche Bank reissued a “neutral” rating on shares of Roche in a research note on Wednesday, March 21st. Five equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of CHF 253.30.

How to Become a New Pot Stock Millionaire

Shares of ROG traded down CHF 1.20 on Tuesday, reaching CHF 219.60. The stock had a trading volume of 3,740,000 shares, compared to its average volume of 2,090,000. Roche has a twelve month low of CHF 214.30 and a twelve month high of CHF 273.

WARNING: “Roche (VTX:ROG) Given a CHF 300 Price Target by Goldman Sachs Analysts” was originally reported by Macon Daily and is the sole property of of Macon Daily. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://macondaily.com/2018/04/12/roche-rog-pt-set-at-chf-300-by-goldman-sachs-updated-updated.html.

Roche Company Profile

Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply